(The Business Insider) When Sean Stiefel told his dad two years ago he was going to invest in an Uruguayan cannabis company after getting pitched on the deal by a broker, the reaction was laughter.But that bet paid off in a big way. Stiefel, along with his partner John Kaden, invested in International Cannabis Corp — a producer of CBD (an extract from the cannabis plant used for medicinal purposes) — at a $40 million valuation and exited at a $160 million valuation only four months later.
A Hedge Fund That Focuses Solely On Marijuana Is Crushing It
This entry was posted in Syndicated. Bookmark the permalink.
